Tuesday, April 15, 2014 5:28 PM PT
By DAVID LEE 

(CN) - Victims of a $7 billion Ponzi scheme failed to show that federal regulators dropped the ball in not catching R. Allen Stanford earlier, the 5th Circuit ruled. 

By ELIZABETH WARMERDAM 

     (CN) - In seven-year battle over trading technology, a federal judge improperly gutted the claim of a patent owned by International Securities Exchange, the Federal Circuit ruled. 

By ADAM KLASFELD 

     MANHATTAN (CN) - Goldman Sachs need not face a $63 million case alleging that it helped clients pull off a fraud that sank a cable company more than a decade ago, the 2nd Circuit ruled. 

By LORRAINE BAILEY 

     
     (CN) - Shareholders cannot sue BioMimetic Therapeutics for its "rosy assessments" of a bone therapy device's prospects for FDA approval because the company believed its own statements, the 6th Circuit ruled. 

By PHILIP A. JANQUART 

     (CN) - A federal judge has thrown out claims that Hewlett-Packard Co. should have suspended employee investments after mismanagement destroyed stock prices. 

By PHILIP A. JANQUART 

     (CN) - A maker of broadband wireless devices plagued by a massive counterfeiting operation need not face shareholder claims, a federal judge ruled. 

By LORRAINE BAILEY 

     
     (CN) - In a "no-win situation," a claimant is either too late or too early to object to the sale of Impact, a company that allegedly operated as a Ponzi scheme, the 10th Circuit ruled. 

By LORRAINE BAILEY 

     (CN) - The 2nd Circuit upheld the conviction and sentence of former Goldman Sachs director Rajat Gupta who gave insider trading information to Galleon hedge fund founder Raj Rajaratnam. 

By LORRAINE BAILEY 

     (CN) - Aveo Pharmaceuticals and its board misrepresented the prospects of its cancer drug tivozanib, and the company's share price dropped more than 90 percent when the FDA unexpectedly declined to approve the drug, a shareholders claim in a derivative action.

By PHILIP A. JANQUART 

     (CN) - Sotheby's board of directors adopted a "poison pill" strategy to protect entrenched board members from being voted out, shareholders claim in federal court

By JON CHOWN 

           SAN FRANCISCO (CN) - With Marvell Technology Group facing a $1 billion patent infringement judgment, shareholders filed a class action derivative complaint against the company and seven officers and directors.

By PHILIP A. JANQUART 

     
     (CN) - Top executives at Weight Watchers International Inc. inflated stock prices before dumping their personal holdings in the company, shareholders claim in federal court.

By NICKEESHA SWABY 

     (CN) - Biopharmaceutical company Geron Corp. failed to disclose poor results for its flagship cancer treatment drug imetelstat between June 16, 2013 to March 11, 2014 causing a dramatic decline in the company's stock price, investors claim in court.

By REBECCA KEARN 

     SAN JOSE, Calif. (CN) - Stock prices for Intuitive Surgical dropped from $573 to $393 per share when it was found that the company had grossly underreported injuries and deaths caused by its da Vinci robotic surgery device, shareholders claim in a federal derivative complaint.

By NICKEESHA SWABY 

     (CN) - Safeway Inc. investors claim the company is being sold on the cheap to Albertson's in a transaction valued at $9 billion.

By LORRAINE BAILEY 

     (CN) - Apple shareholders claim in a derivative action that the company's board of directors is responsible for participating in a Silicon Valley conspiracy to fix tech industry wages, and thereby exposing the company to billions in potential wage restitution.

By PHILIP A. JANQUART 

     (CN) - CytRx Corp. paid writers to author articles about the biopharmaceutical company to artificially inflate its stock price, shareholders claim in a federal class action.

By PHILIP A. JANQUART 

     (CN) - A $45.2 billion merger between Time Warner Cable Inc. and Comcast Corp. would create a "behemoth" that is "too big to sell," shareholders claim in a class action.

     WASHINGTON (CN) - Hewlett-Packard will pay $108 million to settle SEC and federal prosecutors' charges of bribing officials in three foreign countries to get "lucrative public contracts." 

By ADAM KLASFELD 

     MANHATTAN (CN) - Two Texas tycoons played a "global game of hopscotch" by hiding corporate assets in offshore accounts for 13 years, federal regulators told a jury.

By NICKEESHA SWABY 

     (CN) - The Financial Industry Regulatory Authority is failing to provide adequate background checks of current and potential stockbrokers through its BrokerCheck disclosure system, a report by the Public Investors Arbitration Bar Association says.  

     WASHINGTON (CN) - A proprietary trading firm on Long Island and its owner agreed to pay a record $7.2 million to settle charges of short-selling violations, the SEC said. 

     LOS ANGELES (CN) - The SEC obtained an emergency order freezing accounts "holding money stolen from U.S. investors by Fleet Mutual Wealth Limited and MWF Financial - collectively known as Mutual Wealth," the agency said Wednesday. 

By LORRAINE BAILEY 

     
     (CN) - Securities and Exchange Commission employees make significantly above-average returns by selling stock ahead of a drop in price, a new study by a Emory University Professor and a Georgia State University Ph.D. student suggests.  

By LORRAINE BAILEY 

     (CN) - The Federal Reserve Board will give banks two extra years to divest from collateralized loan obligations as required by the Volcker rule.

By PHILIP A. JANQUART 

     (CN) - A new regulatory tool proposed by the Financial Industry Regulatory Authority is "massive" and "invasive," according to the Securities Industry and Financial Markets Association.